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DDiscussion
Dr T. Sundt (Rochester, Minn). I congratulate the authors on do-
ing this study. A prospectively randomized study isn’t an easy thing
to do. I guess I should add that my only conflict of interest is that I
have less concern about the controversy over on-pump versus off-
pump than I have about the use of arterial grafts. I think as a group,
cardiac surgeons would have done well to put more of our energy
into understanding the role of arterial grafts.
Nonetheless, the controversy over off-pump surgery continues,
and this is an important article. The fact that the controversy con-
tinues begs the question ‘‘Why is it that after over a decade of ex-
ploring this matter, the adoption of off-pump surgery is still pretty
modest?’’ Today, only approximately 20% of coronary revascular-
izations are done off-pump despite multiple retrospective studies
that have suggested a benefit to eliminating the pump. Why is
that? Part of the answer is that most of the randomized studies per-
formed thus far have demonstrated a relatively modest advantage to
the off-pump strategy, including little neurocognitive benefit and
a modest mortality benefit if any at all. The advocates of the off-
pump approach point to reductions in blood transfusion require-
ments and ICU length of stay, but up to now, little has been shown
with regard to the outcome that most grabs our attention: mortality.
The reason for this disconnect between retrospective and prospec-
tive studies on this subject is the same as the reason that it is difficult
to show a difference in mortality rate between PCI and coronary by-
pass. As David Taggert has argued vehemently, it is the low-risk
patients who are entered into the randomized studies, and if low-
risk patients are entered into randomized studies, you are unlikely
to see a mortality benefit regardless of what you do! So I congrat-
ulate you in particular in taking the necessary step in entering the
high-risk patients. They are indeed the ones in whom we might ex-
pect to see a difference in mortality, and you have successfully
demonstrated that. This is an important step.
With those comments, I have just a couple of questions. It is
a well-written and beautifully presented article. One question is
in regard to the randomization process. Were the same surgeons do-
ing the on-pump and off-pump cases? If they were not, then it could
be that more skilled surgeons were doing the off-pump cases than
the on-pump cases, and in fact we are looking at a surrogate for sur-
gical skill.
Dr Fattouch. This work is part of our experience in the high-risk
patients with STEMI who underwent CABG at our institution. We
started this experience at the University of Palermo in 2002, and
since the beginning of our experience, in collaboration with inter-
ventional cardiologists in the West Sicily district, we aimed to treat
these patients. Encouraged by our initial results obtained with off-
pump CABG, we designed this randomized study to evaluate the
effects of off-pump versus on-pump CABG in high-risk patients
with STEMI who underwent CABG in the early phase. We started
this study because our opinion about the superiority of off-pump
CABG in patients with STEMI is supported by the fact that avoid-
ing CPB, and not only the conventional cardioplegic arrest, leads torgery c March 2009
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microvasculature of monomorphonuclear cells, which have an im-
portant role in postoperative reperfusion/ischemia damage. More-
over, the postoperative improvement of myocardial function that
was observed in the patients who underwent off-pump surgery is
due to the fact that in on-pump surgery the heart is empty and in
an empty heart the left ventricular wall geometry change leads to
impedance of coronary collateral flow supplying ischemic areas
of myocardium. The patency of these collaterals is important in
these patients to limit the extension of the area of ischemic myocar-
dial damage. Moreover, it has been shown that normal interventric-
ular septum movement is better preserved after off-pump surgery,
which improves LV function. Finally, we have a team dedicated
for this type of surgery, and all cases were done by the same
team of surgeons with high expertise in coronary artery surgery
and specifically in off-pump CABG.
Dr Sundt. A second question would be about the number of
grafts per patient. They are clearly similar between both groups
but rather modest, less than 3 grafts per patient in both cases. Do
you have data about the number of diseased vessels and complete-
ness of revascularization, or is the low number of grafts a reflection
of the patients’ extremis? Do you tend to minimize the number of
grafts in these patients? Is this a low number for you?
Dr Fattouch. In our series, the mean number of grafts per pa-
tient was 2.8 in the on-pump group and 2.6 in the off-pump group;
they are clearly similar between both groups without a statistically
significant difference. So, I agree with you that less than 3 grafts per
patient could seem modest but reflects honestly what we observed.
In these high-risk patients with STEMI, sometimes with cardiac
shock, life-threatening arrhythmias, and multivessel disease, our
policy was to perform complete myocardial revascularization.
Dr Sundt. Do you know what percentage of patients with AMI
from your network wound up coming to the operating room? WeThe Journal of Thoracic and Cjust don’t see it very often. It is uncommon for us to see a patient
in the operating room with an AMI. Most of them are rescued in
the catheter laboratory.
Dr Fattouch. The overall incidence of patients with STEMI
who need early urgent or emergency CABG is approximately 3%
to 4% among all patients who have an AMI. To answer the second
part of your question, I think that we observed this high number of
patients at our institution because we have a district network for the
treatment of these patients in collaboration with cardiologists work-
ing in several coronary ICUs and catheter laboratories since 2002.
So, in our institution we operated on more than 300 patients in the
evolving phase of STEMI, and the results are acceptable.
Dr P. Kurlansky (Miami, Fla). I also congratulate you on con-
ducting an extremely difficult study. The use of cardioplegic arrest
not only provides the opportunity for operating in a silent, bloodless
field but also provides the opportunity for substrate enhancement,
which may be particularly relevant to this particular group of pa-
tients who are acutely ischemic. In your experience or in the study,
was anything done specifically to alter the mechanisms or method-
ology of cardioplegia to provide specific substrate enhancement for
this particularly ill group of patients.?
Dr Fattouch. I think that off-pump CABG is better and superior
to on-pump in these patients because by using an intracoronary
shunt, you can conserve the native blood flow and the opportunity
to supply substrate to the ischemic myocardium. However, in the
case of occluded vessel, I think that a delay for 10 minutes in the
beating heart, the time we need to put the graft and supply blood
flow, is not an additional risk factor for ischemic myocardium.
So, it is evident that in this case we must first address the occluded
guilty vessel. Finally, in patients undergoing on-pump CABG, we
use blood cardioplegia under a normothermic CPB, which is the
best option, in our opinion. Currently, we avoid the use of CPB
for all of the reasons that I have discussed with Dr Sundt.ardiovascular Surgery c Volume 137, Number 3 657
